Caledonia Investments PLC Pfizer Inc Transaction History

Caledonia Investments PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 12, 2020	SELL	$27.03 - $38.62 $9.84 Million - $14.1 Million	-364,000 Closed	0 $0
Q4 2018 Jan 10, 2019	SELL	$38.47 - $43.86 $2.31 Million - $2.63 Million	-60,000 Reduced 14.15%	364,000 $15.9 Million
Q2 2018 Jul 10, 2018	BUY	$32.98 - $35.16 $2.14 Million - $2.29 Million	65,000 Added 18.11%	424,000 $15.4 Million
Q3 2017 Oct 12, 2017	BUY	$31.0 - $34.15 $11.1 Million - $12.3 Million	359,000	359,000 $12.8 Million

3,257

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Caledonia Investments PLC, based on Form 13F filings with the SEC.

Stay updated on Caledonia Investments PLC with notifications on news.